Income Statement Safeguard Scientifics, Inc.

Stocks

SFES

US7864493066

Investment Management & Fund Operators

Market Closed - OTC Markets 12:29:40 2026-05-28 EDT			5-day change	1st Jan Change
0.4900 ^USD	+13.98%		+25.64%	-39.13%

24-12-29	N-Power Medicine, Inc. acquired Syapse, Inc. from Merck Global Health Innovation Fund, LLC and Innovatus Capital Partners, LLC.	CI
24-03-26	Tranche Update on Safeguard Scientifics, Inc.'s Equity Buyback Plan announced on July 28, 2015.	CI

16e58a4d96b71f0.7n8hM4pyofBqgBFt6vmKRab37iSlPil5AsJtItN9dmw.3Ex3B70Vz5cpyGcV05i4CM2ZoB2Udn0VZoACQLpNGhqPB3dyskbUmFn2VA

Published financial data: SAFEGUARD SCIENTIFICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Selling General & Admin Expenses, Total	9.98M	8.17M	6.45M	4.78M	5.68M
Other Operating Expenses, Total	9.98M	8.17M	6.45M	4.78M	5.68M
Operating Income	-9.98M	-8.17M	-6.45M	-4.78M	-5.68M
Interest Expense, Total	-14.02M	-	-	-	-
Interest And Investment Income	2.04M	261K	276K	794K	903K
Net Interest Expenses	-11.98M	261K	276K	794K	903K
Income (Loss) On Equity Invest.	64.27M	-20.7M	11.85M	-6.98M	-7.08M
Other Non Operating Income (Expenses)	1M	-1.45M	-644K	392K	1.87M
EBT, Excl. Unusual Items	43.31M	-30.06M	5.02M	-10.57M	-10M
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	4.45M	-7.56M	21.98M	-3.69M	169K
Asset Writedown	-	-	-	-	-
Other Unusual Items	6.8M	-	-	-	-
EBT, Incl. Unusual Items	54.56M	-37.62M	27M	-14.26M	-9.83M
Earnings From Continuing Operations	54.56M	-37.62M	27M	-14.26M	-9.83M
Net Income to Company	54.56M	-37.62M	27M	-14.26M	-9.83M
Net Income - (IS)	54.56M	-37.62M	27M	-14.26M	-9.83M
Net Income to Common Incl Extra Items	54.56M	-37.62M	27M	-14.26M	-9.83M
Net Income to Common Excl. Extra Items	54.56M	-37.62M	27M	-14.26M	-9.83M
Per Share Items
Net EPS - Basic	2.64	-1.81	1.36	-0.87	-0.61
Basic EPS - Continuing Operations	2.64	-1.81	1.36	-0.87	-0.61
Basic Weighted Average Shares Outstanding	20.64M	20.75M	19.83M	16.34M	16.22M
Net EPS - Diluted	2.64	-1.81	1.36	-0.87	-0.61
Diluted EPS - Continuing Operations	2.64	-1.81	1.36	-0.87	-0.61
Diluted Weighted Average Shares Outstanding	20.64M	20.75M	19.83M	16.34M	16.22M
Normalized Basic EPS	1.31	-0.91	0.16	-0.4	-0.39
Normalized Diluted EPS	1.31	-0.91	0.16	-0.4	-0.39
Payout Ratio	-	-	-	-	-59.21
Supplemental Items
EBITDA	-9.17M	-7.36M	-	-	-
EBITA	-9.98M	-8.17M	-6.45M	-4.78M	-5.68M
EBIT	-9.98M	-8.17M	-6.45M	-4.78M	-5.68M
EBITDAR	-8.67M	-6.86M	-	-	-
Normalized Net Income	27.07M	-18.79M	3.14M	-6.61M	-6.25M
Interest on Long-Term Debt	14M	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	9.98M	8.17M	6.45M	4.78M	5.68M
Net Rental Expense, Total	500K	500K	500K	-	-
Imputed Operating Lease Interest Expense	1.54M	-	-	-	-
Imputed Operating Lease Depreciation	-1.04M	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	1.24M	965K	1.78M	1.44M	1.12M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.24M	965K	1.78M	1.44M	1.12M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	25.03M	15.6M	24.74M	13.33M	9.5M
Short Term Investments	-	-	4.55M	6.82M	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	25.03M	15.6M	29.29M	20.15M	9.5M
Prepaid Expenses	1.3M	462K	965K	1.25M	394K
Restricted Cash	25K	-	25K	25K	19K
Total Current Assets	26.35M	16.06M	30.28M	21.42M	9.91M
Net Property Plant And Equipment	2.1M	1.79M	1.56M	1.29M	971K
Long-term Investments	62.03M	47.77M	21.97M	10.16M	11.3M
Loans Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	17.1M	3.41M	217K	4.82M	652K
Total Assets	108M	69.04M	54.03M	37.69M	22.84M
Liabilities
Accounts Payable, Total	39K	56K	41K	16K	107K
Accrued Expenses, Total	1.99M	3.09M	1.32M	1.37M	1.45M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	399K	327K	375K	429K	489K
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	2.43M	3.47M	1.73M	1.82M	2.05M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	2.38M	2.05M	1.68M	1.25M	760K
Pension & Other Post Retirement Benefits	-	-	-	-	-
Other Non Current Liabilities	1.03M	637K	50K	50K	50K
Total Liabilities	5.84M	6.16M	3.46M	3.12M	2.86M
Common Stock, Total	2.16M	2.16M	2.16M	2.16M	2.16M
Additional Paid In Capital	811M	808M	807M	805M	794M
Retained Earnings	-697M	-737M	-710M	-724M	-734M
Treasury Stock	-14.02M	-10.2M	-48.57M	-48.41M	-42.42M
Comprehensive Income and Other	-25K	-25K	-25K	-25K	-25K
Total Common Equity	102M	62.88M	50.57M	34.58M	19.98M
Total Equity	102M	62.88M	50.57M	34.58M	19.98M
Total Liabilities And Equity	108M	69.04M	54.03M	37.69M	22.84M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.65M	20.94M	16.63M	16.27M	16.72M
ECS Total Common Shares Outstanding	20.64M	20.88M	16.5M	16.1M	16.63M
Book Value / Share	4.93	3.01	3.06	2.15	1.2
Tangible Book Value	102M	62.88M	50.57M	34.58M	19.98M
Tangible Book Value Per Share	4.93	3.01	3.06	2.15	1.2
Total Debt	2.78M	2.38M	2.05M	1.68M	1.25M
Net Debt	-22.25M	-13.22M	-27.24M	-18.47M	-8.25M
Debt Equivalent Oper. Leases	4M	4M	4M	-	-
Equity Method Investments, Total	34.54M	27.82M	21.21M	8.85M	8.5M
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	54.56M	-37.62M	27M	-14.26M	-9.83M
Depreciation & Amortization - CF	1.07M	311K	229K	271K	319K
Depreciation & Amortization, Total	1.07M	311K	229K	271K	319K
Amortization of Deferred Charges, Total - (CF)	3.45M	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	20.04M	2.52M	3.69M	631K
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-64.27M	9.42M	-11.85M	6.98M	6.08M
Stock-Based Compensation (CF)	1.24M	965K	1.78M	1.44M	1.12M
Other Operating Activities, Total	-11.85M	-1.05M	-24.56M	-477K	-1.67M
Change In Accounts Receivable	-	-	-	-	-
Change In Accounts Payable	-3.35M	-77K	-3.04M	-374K	178K
Change in Other Net Operating Assets	-823K	-137K	-238K	-534K	-146K
Cash from Operations	-19.97M	-8.14M	-8.15M	-3.26M	-3.31M
Capital Expenditure	-	-	-	-	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	131M	369K	60.83M	1.01M	5.97M
Other Investing Activities, Total	-4.3M	-1.64M	-2.72M	-5.67M	-250K
Cash from Investing	126M	-1.27M	58.11M	-4.66M	5.72M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-68.57M	-	-	-	-
Total Debt Repaid	-68.57M	-	-	-	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-236K	-40K	-40.8M	-3.49M	-433K
Common Dividends Paid	-	-	-	-	-5.82M
Common & Preferred Stock Dividends Paid	-	-	-	-	-5.82M
Special Dividend Paid	-20.68M	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-89.48M	-40K	-40.8M	-3.49M	-6.25M
Net Change in Cash	16.85M	-9.45M	9.16M	-11.41M	-3.84M
Supplemental Items
Cash Interest Paid	11.5M	-	-	-	-
Levered Free Cash Flow	-13.24M	-1.85M	-4.34M	-1.53M	-1.08M
Unlevered Free Cash Flow	-7.93M	-1.85M	-4.34M	-1.53M	-1.08M
Change In Net Working Capital	4M	-1.97M	2.31M	257K	-1.03M
Net Debt Issued / Repaid	-68.57M	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-4.93	-5.78	-6.55	-6.51	-11.74
Return on Total Capital	-5.16	-6.01	-6.84	-6.72	-12.36
Return On Equity %	64.68	-45.7	47.61	-33.5	-36.03
Return on Common Equity	64.68	-45.7	47.61	-33.5	-36.03
Short Term Liquidity
Current Ratio	10.85	4.63	17.46	11.79	4.84
Quick Ratio	10.3	4.5	16.89	11.09	4.64
Operating Cash Flow to Current Liabilities	-8.22	-2.35	-4.7	-1.79	-1.62
Long Term Solvency
Total Debt/Equity	2.73	3.79	4.06	4.85	6.25
Total Debt / Total Capital	2.66	3.65	3.9	4.63	5.88
LT Debt/Equity	2.34	3.27	3.32	3.61	3.8
Long-Term Debt / Total Capital	2.28	3.15	3.19	3.45	3.58
Total Liabilities / Total Assets	5.42	8.92	6.41	8.27	12.51
EBIT / Interest Expense	-0.71	-	-	-	-
EBITDA / Interest Expense	-0.62	-	-	-	-
(EBITDA - Capex) / Interest Expense	-0.62	-	-	-	-
Total Debt / EBITDA	-0.32	-0.35	-0.34	-0.39	-
Net Debt / EBITDA	2.57	1.93	4.58	4.32	-
Total Debt / (EBITDA - Capex)	-0.32	-0.35	-0.34	-0.39	-
Net Debt / (EBITDA - Capex)	2.57	1.93	4.58	4.32	-
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-25.89	-15.17	-	-	-
EBITA, 1 Yr. Growth %	-23.63	-13.88	-20.98	-26	19.02
EBIT, 1 Yr. Growth %	-23.63	-13.88	-20.98	-26	19.02
Earnings From Cont. Operations, 1 Yr. Growth %	-449.1	-168.94	-171.79	-152.82	-31.09
Net Income, 1 Yr. Growth %	-449.1	-168.94	-171.79	-152.82	-31.09
Normalized Net Income, 1 Yr. Growth %	-773.32	-169.41	-116.72	-143.52	-5.46
Diluted EPS Before Extra, 1 Yr. Growth %	-447.02	-168.66	-175.03	-164.19	-30.13
Net Property, Plant and Equip., 1 Yr. Growth %	160.02	-14.8	-12.79	-17.36	-24.73
Total Assets, 1 Yr. Growth %	-26.18	-35.83	-21.74	-30.24	-39.41
Tangible Book Value, 1 Yr. Growth %	51.9	-38.2	-19.58	-31.62	-42.21
Common Equity, 1 Yr. Growth %	51.9	-38.2	-19.58	-31.62	-42.21
Cash From Operations, 1 Yr. Growth %	-23.3	-59.22	0.11	-60.03	1.53
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	65.07	-85.65	133.84	-64.83	-29.21
Unlevered Free Cash Flow, 1 Yr. Growth %	218.25	-75.65	133.84	-64.83	-29.21
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-26.12	-22.9	-	-	-
EBITA, 2 Yr. CAGR %	-23.67	-20.96	-17.5	-23.53	-6.16
EBIT, 2 Yr. CAGR %	-23.67	-20.96	-17.5	-23.53	-6.16
Earnings From Cont. Operations, 2 Yr. CAGR %	-21.51	55.14	-29.65	-38.42	-39.67
Net Income, 2 Yr. CAGR %	-21.51	55.14	-29.65	-38.42	-39.67
Normalized Net Income, 2 Yr. CAGR %	-29.95	116.18	-65.94	-40.69	-35.85
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.01	54.36	-28.23	-30.6	-33.03
Net Property, Plant and Equip., 2 Yr. CAGR %	17.84	48.84	-13.8	-15.11	-21.13
Total Assets, 2 Yr. CAGR %	-21.92	-31.17	-29.13	-26.11	-34.99
Tangible Book Value, 2 Yr. CAGR %	11.53	-3.11	-29.5	-25.84	-37.14
Common Equity, 2 Yr. CAGR %	11.53	-3.11	-29.5	-25.84	-37.14
Cash From Operations, 2 Yr. CAGR %	-2.03	-44.07	-36.11	-36.75	-36.3
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-6.05	-51.91	-42.08	-9.31	-50.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-19.23	-13.72	-24.54	-9.31	-50.1
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-20.65	-24.07	-	-	-
EBITA, 3 Yr. CAGR %	-18.87	-21.88	-20.97	-20.44	-11.38
EBIT, 3 Yr. CAGR %	-18.87	-21.88	-20.97	-20.44	-11.38
Earnings From Cont. Operations, 3 Yr. CAGR %	34.83	-24.83	20	-36.06	-36.07
Net Income, 3 Yr. CAGR %	34.83	-24.83	20	-36.06	-36.07
Normalized Net Income, 3 Yr. CAGR %	28.77	-30.17	-7.9	-37.5	-30.72
Diluted EPS Before Extra, 3 Yr. CAGR %	34.12	-25.25	21.37	-30.85	-30.44
Net Property, Plant and Equip., 3 Yr. CAGR %	3.9	5.76	24.55	-15.01	-18.44
Total Assets, 3 Yr. CAGR %	-22.58	-26.86	-28.16	-29.5	-30.84
Tangible Book Value, 3 Yr. CAGR %	-15.69	-8.4	-8.94	-30.22	-31.76
Common Equity, 3 Yr. CAGR %	-15.69	-8.4	-8.94	-30.22	-31.76
Cash From Operations, 3 Yr. CAGR %	2.29	-26.85	-32.1	-45.36	-25.94
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	20.64	-50.18	-18.53	-50.95	-16.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.27	-46.56	20.3	-41.49	-16.5
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-13.46	-15.78	-	-	-
EBITA, 5 Yr. CAGR %	-12.05	-14.19	-19.16	-22.55	-15.34
EBIT, 5 Yr. CAGR %	-12.05	-14.19	-19.16	-22.55	-15.34
Earnings From Cont. Operations, 5 Yr. CAGR %	60.34	-8.77	3.94	-30.6	-8.86
Net Income, 5 Yr. CAGR %	60.34	-8.77	3.94	-30.6	-8.86
Normalized Net Income, 5 Yr. CAGR %	3.35	-12.82	-24.35	-34.58	9.22
Diluted EPS Before Extra, 5 Yr. CAGR %	60.23	-8.66	4.44	-27.44	-4.32
Net Property, Plant and Equip., 5 Yr. CAGR %	76.4	-3.55	-3.58	-3.14	3.74
Total Assets, 5 Yr. CAGR %	-19.51	-23.11	-25.27	-26.56	-30.97
Tangible Book Value, 5 Yr. CAGR %	-16.97	-20.3	-21.51	-15.82	-21.49
Common Equity, 5 Yr. CAGR %	-16.97	-20.3	-21.51	-15.82	-21.49
Cash From Operations, 5 Yr. CAGR %	-0.22	-14.43	-15.26	-30.98	-33.81
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	1.03	-35.53	-10.47	-36.69	-33.04
Unlevered Free Cash Flow, 5 Yr. CAGR %	-6.63	-34.42	-7.04	-33.97	-15.4